Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1) - Trial NCT03931161
Access comprehensive clinical trial information for NCT03931161 through Pure Global AI's free database. This Phase 4 trial is sponsored by Imperial College Healthcare NHS Trust and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Imperial College Healthcare NHS Trust
Timeline & Enrollment
Phase 4
Sep 04, 2019
Sep 04, 2023
Primary Outcome
Change in lipid-rich necrotic core
Summary
This is a phase IV, randomised, placebo-controlled, double-blind, parallel group study to
 determine the effect of Evolocumab treatment on carotid plaque morphology and composition in
 asymptomatic patients with 50% carotid artery stenosis.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03931161
Non-Device Trial